Home/Nuvectis Pharma/Ron Bentsur
RB

Ron Bentsur

Chairman, Chief Executive Officer and President

Nuvectis Pharma

Therapeutic Areas

Nuvectis Pharma Pipeline

DrugIndicationPhase
NXP900Advanced solid tumorsPhase 1b
NXP800Platinum-resistant, ARID1a-mutated ovarian cancerPhase 1b